• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Baxter International

Baxter International

Baxter International Inc BAX 4 Star

Last Price$68.52Day Change (%)-0.03%
Open Price$68.81Day Change ($)-0.02
Day Range68.34–68.8552-Week Range65.94–77.31

As of Mon 3/30/2015 11:52:00 AM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis

    CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis

  2. Research and Markets: Global Dialysis Market Report: 2015 Edition

    Research and Markets: Global Dialysis Market Report: 2015 Edition

  3. CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With Myelofibrosis

    CTI BioPharma Announces Publication In Blood Of Phase 2 Results Of Pacritinib In Patients With Myelofibrosis

  4. Research and Markets: Liver Cancer Partnering Deals and Agreements 2010-2015 - Analysis from the World's Leading Healthcare Companies

    Research and Markets: Liver Cancer Partnering Deals and Agreements 2010-2015 - Analysis from the World's Leading Healthcare Companies

  5. Research and Markets: Lymphoma Partnering Deals and Agreements Analysis 2010-2015

    Research and Markets: Lymphoma Partnering Deals and Agreements Analysis 2010-2015

  6. Research and Markets: 2010-2015 Myocardial Infarction Partnering Deals and Agreements Deals Analysis for the World's Leading Healthcare Companies

    Research and Markets: 2010-2015 Myocardial Infarction Partnering Deals and Agreements Deals Analysis for the World's Leading Healthcare Companies

  7. Research and Markets: Lung Cancer Partnering Deals and Agreements Analysis 2010-2015

    Research and Markets: Lung Cancer Partnering Deals and Agreements Analysis 2010-2015

  8. Research and Markets: Prostate Cancer Partnering Deals and Agreements Analysis 2010-2015

    Research and Markets: Prostate Cancer Partnering Deals and Agreements Analysis 2010-2015

  9. Research and Markets: Brain Cancer Partnering Deals and Agreements 2010-2015

    Research and Markets: Brain Cancer Partnering Deals and Agreements 2010-2015

  10. Moats and Growth Drivers Look Solid for Post-Split Baxter

    Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.